Amedisys Announces First Quarter Earnings Release and Conference Call Date

Amedisys Announces First Quarter Earnings Release and Conference Call Date

BATON ROUGE, La., April 25, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc.
(Nasdaq:AMED), one of America's leading home health and hospice care
companies, announced today that it will host a conference call to discuss
results for the first quarter ended on March 31, 2014 on Thursday, May 8, 2014
at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue
its quarterly earnings release prior to hosting the conference call.

To participate on the conference call, please call a few minutes before 10:00
a.m. ET to either (877) 512-9171 (Toll free) or (815) 573-0979, use conference
ID #35785199. A replay of the conference call will be available through June
8, 2014. The replay dial in number is (855) 859-2056 (Toll free) or (404)
537-3406 (Toll) and use conference ID #35785199.

A live webcast of the call will be accessible through our website on our
Investor Relations section at the following web address:

Amedisys, Inc. (the "Company") is headquartered in Baton Rouge, Louisiana and
our common stock trades on the NASDAQ Global Select Market under the symbol

About Amedisys:

Amedisys, Inc. (Nasdaq:AMED) is a "health care at home" company delivering
personalized home health and hospice care to more than 360,000 patients each
year. Amedisys is focused on delivering the care that is best for our
patients, whether that is home-based recovery and rehabilitation after an
operation or injury, care focused on empowering them to manage a chronic
disease, palliative care for those with a terminal illness, or hospice care at
the end of life. For more information about Amedisys, please visit:

We use our company website as a channel of distribution for important company
information. Important information, including press releases, analyst
presentations and financial information regarding the Company is routinely
posted on and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on our website
home page. We will also use our website to expedite public access to
time-critical information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and Exchange
Commission ("SEC") disclosing the same information. In addition, we make
available on the Investor Relations subpage of our website (under the link
"SEC filings") free of charge our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms
3, 4 and 5 and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct
and the charters for the Audit, Compensation, Nominating and Corporate
Governance, Quality of Care and Compliance and Ethics Committees of our Board
are also available on the Investor Relations subpage of our website (under the
link "Corporate Governance").

CONTACT: Amedisys, Inc.
         David Castille
         Director, Treasury/Finance

Amedisys, Inc. logo
Press spacebar to pause and continue. Press esc to stop.